ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.83
0.07%
Dow Jones
39,797.79
-0.51%
US Dollar vs MXN
16.55905
-0.25%
Brent Oil
83.585
-0.01%
Bitcoin
69,851.60
5.40%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Decibel Therapeutics Inc (DBTX)

  7. Decibel Therapeutics Inc (DBTX) Noticias

DBTX

Decibel Therapeutics (DBTX)

Decibel Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DBTX
FechaHoraFuenteTítuloSímboloCompañía
10/10/202315:56Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:DBTXDecibel Therapeutics Inc
25/09/202315:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202308:09Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202308:00Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202307:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202307:53Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DBTXDecibel Therapeutics Inc
25/08/202308:17Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:DBTXDecibel Therapeutics Inc
11/08/202306:45GlobeNewswire Inc.Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:DBTXDecibel Therapeutics Inc
11/08/202306:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DBTXDecibel Therapeutics Inc
09/08/202315:55Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202308:34Dow Jones NewsDecibel Therapeutics Shares Surge on Regeneron AcquisitionNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202307:14Dow Jones NewsRegeneron To Acquire Decibel TherapeuticsNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202306:30GlobeNewswire Inc.Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss ProgramsNASDAQ:DBTXDecibel Therapeutics Inc
14/06/202315:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DBTXDecibel Therapeutics Inc
13/06/202315:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DBTXDecibel Therapeutics Inc
02/06/202306:00GlobeNewswire Inc.Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare ConferenceNASDAQ:DBTXDecibel Therapeutics Inc
01/06/202315:30GlobeNewswire Inc.Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingNASDAQ:DBTXDecibel Therapeutics Inc
17/05/202315:30GlobeNewswire Inc.Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy SummitNASDAQ:DBTXDecibel Therapeutics Inc
15/05/202306:45GlobeNewswire Inc.Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate UpdateNASDAQ:DBTXDecibel Therapeutics Inc
15/05/202306:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DBTXDecibel Therapeutics Inc
12/05/202306:00GlobeNewswire Inc.Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTONASDAQ:DBTXDecibel Therapeutics Inc
10/05/202315:30GlobeNewswire Inc.Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual MeetingNASDAQ:DBTXDecibel Therapeutics Inc
28/04/202307:41Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DBTXDecibel Therapeutics Inc
28/04/202307:21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DBTXDecibel Therapeutics Inc
28/04/202307:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DBTXDecibel Therapeutics Inc
14/04/202307:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:DBTXDecibel Therapeutics Inc
30/03/202306:00GlobeNewswire Inc.Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTONASDAQ:DBTXDecibel Therapeutics Inc
28/03/202315:30GlobeNewswire Inc.Decibel Therapeutics to Participate in the Upcoming Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease DaysNASDAQ:DBTXDecibel Therapeutics Inc
21/03/202315:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DBTXDecibel Therapeutics Inc
21/03/202306:00GlobeNewswire Inc.Decibel Therapeutics Appoints Matthew Kapusta to its Board of DirectorsNASDAQ:DBTXDecibel Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DBTX

Su Consulta Reciente

TG
A2R2X5
Total Capital
TG
A189JH
APRR
TSX
ZCPB
BMO Core Plus Bond Fund ...
BIT
P1UGL3
NLBNPIT1UGL3 20991231 15...
TG
ASOL
21Shares
TG
A19M4D
BAT International Finance
TG
A28S8K
PRE Explorer II AS
BIT
P1WOQ2
NLBNPIT1WOQ2 20240619 15...
BIT
P1XWD1
NLBNPIT1XWD1 20261231 60
TSXV
PRH
Pearl River
NASDAQ
ALKSV
Alkermes
TSX
CURA
Curaleaf
HUOB
VINUUSDT
Vita Inu
TSXV
AAC
Arak Resources Ltd.
BOV
REGN34R
Regeneron Pharmaceuticals
TSX
SIH.UN
Sustainable Innovation &...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados